83-5966-54 Gancotamab (ERBB2, EGFR2, CD340) 100ug 591881
特徴
- Gancotamab is under investigation in clinical trial NCT02213744 (MM-302 plus Trastuzumab vs.
- chemotherapy of physician's choice plus Trastuzumab in HER2-positive locally advanced/metastatic breast cancer patients).
- Applications:Suitable for use in ELISA and SDS-PAGE.
- Other applications not tested.
- Recommended Dilution:Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4℃ for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20℃.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size：100ug
- 抗体種類：Mab
- 宿主：human
- Grade：Highly Purified
- Purity：≥95%
- Form：Supplied as a liquid in PBS, pH 7.5.
- Specificity：Recognizes Gancotamab (ERBB2/EGFR2/CD340).
- Isotype：scFv-heavy,l
- Calc Applications Abbrev：E
- Immunogen：Recombinant protein corresponding to ERBB2/EGFR2/CD340 [Homo sapiens], expressed in CHO cells.
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
